Cargando…

Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease

BACKGROUND: Both Parkinson's disease (PD) and multiple system atrophy (MSA) exhibit degeneration of brainstem serotoninergic nuclei, affecting multiple subcortical and cortical serotoninergic projections. In MSA, medullary serotoninergic neuron pathology is well documented, but serotonin system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Kelvin L., Dayalu, Praveen, Koeppe, Robert A., Gilman, Sid, Spears, C. Chauncey, Albin, Roger L., Kotagal, Vikas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669145/ https://www.ncbi.nlm.nih.gov/pubmed/36102173 http://dx.doi.org/10.1002/mds.29220

Ejemplares similares

Regional serotonin terminal density in aging human brain: A [(11)C]DASB PET study
por: Kanel, Prabesh, et al.
Publicado: (2023)

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2010)

Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy
por: Suwijn, S. R., et al.
Publicado: (2014)

Fatigue in Parkinson’s Disease Associates with Lower Ambulatory Diastolic Blood Pressure
por: Kotagal, Vikas, et al.
Publicado: (2019)

The Role of Serotonin in Sleep Disordered Breathing Associated with Parkinson Disease: A Correlative [(11)C]DASB PET Imaging Study
por: Lelieveld, Irene M., et al.
Publicado: (2012)

Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome
por: Albin, Roger L., et al.
Publicado: (2017)

Body mass index and severity of parkinsonism in multiple system atrophy
por: Suzuki, Ai, et al.
Publicado: (2017)

Is PIGD a legitimate motor subtype in Parkinson disease?
por: Kotagal, Vikas
Publicado: (2016)

Serotonin Transporter Gene Polymorphisms and Chronic Illness of Depression
por: Myung, Woojae, et al.
Publicado: (2010)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Miyaue, Noriyuki, et al.
Publicado: (2023)

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
por: Foti, Sandrine C., et al.
Publicado: (2019)

Huntington’s Disease Community Perspectives on Desired Characteristics of Disease Modifying Therapies
por: Gornick, Michele C., et al.
Publicado: (2021)

Racial Differences in Trust and Risk Disclosure Preferences Among Older Registered Research Volunteers Screened for Prodromal Synucleinopathies
por: Marshall, Carly, et al.
Publicado: (2022)

The val(158)met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease
por: Rowe, J.B., et al.
Publicado: (2010)

Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports
por: Stewart, Benjamin, et al.
Publicado: (2020)

Widespread microglial activation in multiple system atrophy
por: Kübler, Dorothee, et al.
Publicado: (2019)

Cholinergic system changes of falls and freezing of gait in Parkinson's disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2019)

Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography
por: Arakawa, Ryosuke, et al.
Publicado: (2018)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
por: Alster, Piotr, et al.
Publicado: (2022)

Pareidolia in Parkinson's Disease and Multiple System Atrophy
por: Kurumada, Kentaro, et al.
Publicado: (2021)

Progressive hemifacial atrophy with ciliary body atrophy and ocular hypotony
por: Kini, T Ashwini, et al.
Publicado: (2015)

Altered Resting State Cortico-Striatal Connectivity in Mild to Moderate Stage Parkinson's Disease
por: Kwak, Youngbin, et al.
Publicado: (2010)

Lack of association between serotonin transporter 5-HTT gene polymorphism and endometriosis in an Italian patient population
por: Megiorni, Francesca, et al.
Publicado: (2014)

No Dopamine Agonist Modulation of Brain [(18)F]FEOBV Binding in Parkinson’s Disease
por: Albin, Roger L., et al.
Publicado: (2022)

Serotonin and serotonin transporter levels in autistic children
por: Abdulamir, Haidar A., et al.
Publicado: (2018)

Laboratory prognostic factors for the long-term survival of multiple system atrophy
por: Shin, Jung Hwan, et al.
Publicado: (2022)

Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
por: Bailey, Elke Schipani, et al.
Publicado: (2023)

Cognitive correlates of dual tasking costs on the timed up and go test in Parkinson disease
por: Harrie, Ashley, et al.
Publicado: (2022)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
por: Hor, Jia Wei, et al.
Publicado: (2022)

Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease
por: Wang, Yi, et al.
Publicado: (2017)

Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells
por: Singh, Y S, et al.
Publicado: (2012)

Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
por: Bohnen, Nicolaas I, et al.
Publicado: (2021)

Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication
por: Festini, Sara B., et al.
Publicado: (2015)

Chemical and structural investigation of the paroxetine-human serotonin transporter complex
por: Coleman, Jonathan A, et al.
Publicado: (2020)

Cardiovagal Baroreflex Sensitivity in Parkinson's Disease and Multiple-System Atrophy
por: Roy, Sankanika, et al.
Publicado: (2016)

Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease
por: Sun, Zhanfang, et al.
Publicado: (2016)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4983qbotltr9alpkoi9qqacjhf